Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-Fluorouracil-Mediated Cytotoxicity in Multiple Human Cancer Types.
about
Retroviral Replicating Vector Delivery of miR-PDL1 Inhibits Immune Checkpoint PDL1 and Enhances Immune Responses In VitroToca 511 gene transfer and treatment with the prodrug, 5-fluorocytosine, promotes durable antitumor immunity in a mouse glioma model.How We Manage Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA SCID).Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma.Designing and building oncolytic viruses.
P2860
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-Fluorouracil-Mediated Cytotoxicity in Multiple Human Cancer Types.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Retroviral Replicating Vectors ...... n Multiple Human Cancer Types.
@ast
Retroviral Replicating Vectors ...... n Multiple Human Cancer Types.
@en
type
label
Retroviral Replicating Vectors ...... n Multiple Human Cancer Types.
@ast
Retroviral Replicating Vectors ...... n Multiple Human Cancer Types.
@en
prefLabel
Retroviral Replicating Vectors ...... n Multiple Human Cancer Types.
@ast
Retroviral Replicating Vectors ...... n Multiple Human Cancer Types.
@en
P2093
P2860
P356
P1476
Retroviral Replicating Vectors ...... n Multiple Human Cancer Types.
@en
P2093
Carlos E Ibanez
Chris G Twitty
Cindy Burrascano
Daniel J Hogan
Derek Ostertag
Douglas J Jolly
Oscar R Diago
P2860
P356
10.1089/HGTB.2015.106
P577
2015-10-15T00:00:00Z